CALICI (CEO Jaemoon Choi), a leader in AI-driven drug discovery and the biotech industry, has signed a strategic industry-academia cooperation MOU with Kyungbok University (President Jiyong Jeon). The partnership aims to train talent for the biohealth industry and provide students with hands-on education and global career opportunities.

Under the agreement, CALICI will offer research collaboration and practical training using its AI platform Pharmaco-Net® and clinical pharmacology data. Kyungbok University will expand relevant courses in AI-bio convergence, data visualization, and media production. Both institutions plan to collaborate on joint research projects, capstone design programs, and industry-academia seminars.

CEO Jaemoon Choi emphasized, “Through this partnership, we aim to create a model for industry-academia cooperation that drives future medical innovation. AI-based clinical pharmacology analysis is key to accelerating drug development and improving success rates, supporting a globally competitive and innovative business model.”